Tylosin Tartrate
- Manufacturer
- Qilu Pharmaceutical (Inner Mongolia) Co.,Ltd.
- Effective date
- 2025-12-23
- Label type
- BULK INGREDIENT - ANIMAL DRUG
- Version
- 6
- Source
- full-release
- Hydrated at
- 2026-06-01 02:52:15
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Tylosin Tartrate USP
(NON-STERILE POWDER.MEET THE
REQUIREMENTS OF 21 CFR 201.122)
NDC 86098-0001-1
QILU PHARMACEUTICAL (INNER MONGOLIA) CO.,LTD.
ADD:No.2 Wei Si Road, Jinchuannan District, Economy&Technology Development Zone, Hohhot City, China
Batch No.:
Mfg.Date:
Exp.Date: Months
N.W.: KG/Unit
Activity: μg of tylosin per mg,calculated on the dried basis.
Packaging and storage: Preserve in well-closed containers, protected from light, moisture, and excessive heat.Store not to exceed 25°C.
Postcode:010080
Tel:+86-471-3260004
Fax:+86-471-3260005
Website:
www.qlnm-pharma.com
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86098-0001-1 | Tylosin Tartrate | 15 kg in 1 DRUM | powder | 15 | 6 |
Products#
Every source-derived product name is available through these pages.
- Tylosin Tartrate
- TYLOSIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 86098-0001 | 86098-0001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Tylosin Tartrate | 5P4625C51T | ACTIB |
Source Document#
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
